This inventor holds 73 USPTO granted patents and 15 published patent applications and 5 EPO patents, primarily in Biosensor Technology (CPC class G01N). Top assignees: Intel Corporation, Xerox Corporation, Other. Active years: 1997-2018.
Inventors with similar research interests:
Location History:
- Palo Alto, CA (US) (1997 - 2000)
- San Jose, CA (US) (1998 - 2016)
- Lexington, MA (US) (2018)
Company Filing History:
39 out of 56,222 
33 out of 24,257 
1 out of 834,350 Years Active: 1997-2018
Areas of Expertise:
Title: Andrew A. Berlin: Innovator in Biosensing Technologies
Introduction: Andrew A. Berlin, based in San Jose, CA, is a prolific inventor recognized for his significant contributions to the field of biosensors. With an impressive portfolio of 72 patents, Berlin has focused on developing systems and methods for detecting biomolecules, showcasing his commitment to advancing technology in both healthcare and scientific research.
Latest Patents: Among his latest innovations is a groundbreaking patent for a biosensor utilizing a resonator with a functionalized surface. This invention provides an efficient method for detecting the presence of biomolecules in a sample. The device features a piezoelectric resonator whose functionalized surface is engineered to interact with target biomolecules. This interaction modifies the mass and/or charge of the resonator, which in turn alters its frequency response. The frequency response of the resonator post-exposure is then compared to a reference, enabling accurate detection of biomolecules.
Career Highlights: Andrew A. Berlin has spent a significant portion of his career working with prominent technology companies, including Intel Corporation and Xerox Corporation. His experiences at these organizations have greatly influenced his innovative journey, allowing him to apply his theoretical knowledge to practical applications in cutting-edge technologies.
Collaborations: Throughout his career, Berlin has had the opportunity to collaborate with notable colleagues, including Mineo Yamakawa and Warren Bruce Jackson. These collaborations have facilitated the exchange of ideas and further enhanced the development of innovative biosensing technologies.
Conclusion: Andrew A. Berlin stands out as a key figure in the realm of biosensing innovation, with his extensive patent portfolio reflecting his dedication to technological advancement. His work not only contributes to the field of biosensors but also opens new avenues for detecting and analyzing biomolecules, thereby impacting healthcare and research institutions significantly.